Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Thailand school shooting toll rises to nine after death of 12-year-old girl
Thousands told to evacuate in British Columbia as wildfire grows
Three killed in Russian strikes in Kyiv region, official says
Typhoon Dolphin hits Japan's Okinawa, China shuts ports ahead of landfall
Spain to establish border controls against Italy amid migration dispute
